Discharge based processing systems for nitric oxide remediation

An electron beam (EB) flue gas test rig and a dielectric barrier discharge (DBD) reactor were tested for the removal of nitric oxide (NO) from gas stream in separate experiments. In both systems, energised electrons were used to produce radicals that reacted with the pollutants. The EB system was a laboratory scale test rig used to treat emission from a diesel run generator. At 1.0 MeV and 10 mA more than 90% NO removal from flue gases flowing at 120 Nm3/h can be achieved. For higher removal percentage, higher beam current was required. In a related effort, a table top, two tubes DBD reactor was used to process bottled gases containing 106 ppm NO. Total removal (>99%) was achieved when the inlet gas contained only NO and N2. Additional SO2 in the in let gas stream lowered the removal rate but was overcame by scaling up the system to 10 DBD tubes. The system was operated with input AC voltage of 35 kV peak to peak. In the EB treatment system, the amount of NO2 increased at high beam current, showing that the NO was also oxidised in the process. Whereas in the DBD reactor, the amount of NO2 remained insignificant throughout the process. This leads to the conclusion that the DBD reactor is capable of producing total removal of NO. This is highly desirable as post treatment will not be necessary

Biodegradation of carbamazepine using fungi and bacteria

Carbamazepine is an anti-epileptic pharmaceuticalcompound which is frequently detected in wastewater. However, this compound is hardly degraded naturally due to its persistency. Thus, carbamazepine presents in water stream and household water supply as well as wastewater treatment plant. This paper focuses on various species of fungi and bacteria used in carbamazepine biodegradation and the carbamazepine degrading-enzymes involved in the degradation pathways. Selected research papers on carbamazepine biodegradation using fungi and bacteria were reviewed. The efficiency and approaches in term of methodologies and technologies used were highlighted in this paper. Such study sheds light on gaps of study and future research direction on carbamazepine biodegradation.Keywords: biodegradation; carbamazepine; method; pharmaceuticals

A Framework for Tracing the Flavouring Information to Accelerate Halal Certification

Halal industry is a new sector in the manufacturing industry in Malaysia and is a fast-growing global business. In Malaysia, JAKIM is the body responsible in matters relating to approve the halal certification. However, the process of issuing the halal certificate is time consuming. Based on the delay in issuing the halal certificate, this study conducted a case study to examine issues in halal certification. The reasons for the delay in issuing halal certification is the constraints in determining halal status of flavouring due to the absence of halal certificate when auditors were processing the documentation for applying certification. In addition, the inconsistent use of terms among the food producers and the auditors makes it difficult to trace halal status of flavouring. The case study also found that there is no framework that can help to trace the halal status of flavouring ingredient systematically. Thus, the study contributes a framework for tracing flavouring information to accelerate halal certification

Characterization of PVDF-HFP-LiCF3S03-Zr02 nanocomposite polymer electrolyte systems

Nanocomposite polymer electrolytes were prepared by incorporating different amounts of zirconium oxide (Zr02) nanofiller to poly(vinylidene fluoride-co exafluoropropylene)-lithium trifluoromethane sulfonate (PVDF-HFP-LiCF3S03). X-ray diffraction (XRD) study has been carried out to investigate the structural features of the electrolyte films while a.c. impedance spectroscopy has been performed to investigate their electrical properties. The conductivity of nanocomposite polymer electrolyte systems is influenced by nanofiller concentration. The increase in conductivity is attributable to the increase in the fraction of amorphous region and the number of charge carriers and vice versa. The highest conductivity obtained is in the order of 10-3 S cm-1 for the system dispersed with 5 wt% of Zr02 nanofiller

Comparison of diametric and volumetric changes in Stanford type B aortic dissection patients in assessing aortic remodeling post-stent graft treatment

Background: The study aims to analyze the correlation between the maximal diameter (both axial and orthogonal) and volume changes in the true (TL) and false lumens (FL) after stent-grafting for Stanford type B aortic dissection. Method: Computed tomography angiography was performed on 13 type B aortic dissection patients before and after procedure, and at 6 and 12 months follow-up. The lumens were divided into three regions: the stented area (Region 1), distal to the stent graft to the celiac artery (Region 2), and between the celiac artery and the iliac bifurcation (Region 3). Changes in aortic morphology were quantified by the increase or decrease of diametric and volumetric percentages from baseline measurements. Results: At Region 1, the TL diameter and volume increased (pre-treatment: volume =51.4±41.9 mL, maximal axial diameter =22.4±6.8 mm, maximal orthogonal diameter =21.6±7.2 mm; follow-up: volume =130.7±69.2 mL, maximal axial diameter =40.1±8.1 mm, maximal orthogonal diameter =31.9+2.6 mm, P<0.05 for all comparisons), while FL decreased (pre-treatment: volume =129.6±150.5 mL; maximal axial diameter =43.0±15.8 mm; maximal orthogonal diameter =28.3±12.6 mm; follow-up: volume =66.6±95.0 mL, maximal axial diameter =24.5±19.9 mm, maximal orthogonal diameter =16.9±13.7, P<0.05 for all comparisons). Due to the uniformity in size throughout the vessel, high concordance was observed between diametric and volumetric measurements in the stented region with 93% and 92% between maximal axial diameter and volume for the true/false lumens, and 90% and 92% between maximal orthogonal diameter and volume for the true/false lumens. Large discrepancies were observed between the different measurement methods at regions distal to the stent graft, with up to 46% differences between maximal orthogonal diameter and volume. Conclusions: Volume measurement was shown to be a much more sensitive indicator in identifying lumen expansion/shrinkage at the distal stented region

Two new xanthones from Artocarpus obtusus

Two new xanthones, pyranocycloartobiloxanthone A (1) and dihydroartoindonesianin C (2), were isolated from the stem bark of Artocarpus obtusus Jarrett by chromatographic separation. Their structures were determined by using spectroscopic methods and comparison with known related compounds. Pyranocycloartobiloxanthone A (1) showed strong free radical scavenging activity by using DPPH assay as well as cytotoxicity towards K562, HL-60, and MCF7 cell lines

Management and outcomes of gastrointestinal congenital anomalies in low, middle and high income countries: Protocol for a multicentre, international, prospective cohort study

Introduction Congenital anomalies are the fifth leading cause of death in children <5 years of age globally, contributing an estimated half a million deaths per year. Very limited literature exists from low and middle income countries (LMICs) where most of these deaths occur. The Global PaedSurg Research Collaboration aims to undertake the first multicentre, international, prospective cohort study of a selection of common congenital anomalies comparing management and outcomes between low, middle and high income countries (HICs) globally. Methods and analysis The Global PaedSurg Research Collaboration consists of surgeons, paediatricians, anaesthetists and allied healthcare professionals involved in the surgical care of children globally. Collaborators will prospectively collect observational data on consecutive patients presenting for the first time, with one of seven common congenital anomalies (oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation and Hirschsprung''s disease). Patient recruitment will be for a minimum of 1 month from October 2018 to April 2019 with a 30-day post-primary intervention follow-up period. Anonymous data will be collected on patient demographics, clinical status, interventions and outcomes using REDCap. Collaborators will complete a survey regarding the resources and facilities for neonatal and paediatric surgery at their centre. The primary outcome is all-cause in-hospital mortality. Secondary outcomes include the occurrence of postoperative complications. Chi-squared analysis will be used to compare mortality between LMICs and HICs. Multilevel, multivariate logistic regression analysis will be undertaken to identify patient-level and hospital-level factors affecting outcomes with adjustment for confounding factors. Ethics and dissemination At the host centre, this study is classified as an audit not requiring ethical approval. All participating collaborators have gained local approval in accordance with their institutional ethical regulations. Collaborators will be encouraged to present the results locally, nationally and internationally. The results will be submitted for open access publication in a peer reviewed journal

Genome-wide association study for systemic lupus erythematosus in an egyptian population

Systemic lupus erythematosus (SLE) susceptibility has a strong genetic component. Genome-wide association studies (GWAS) across trans-ancestral populations show both common and distinct genetic variants of susceptibility across European and Asian ancestries, while many other ethnic populations remain underexplored. We conducted the first SLE GWAS on Egyptians–an admixed North African/Middle Eastern population–using 537 patients and 883 controls. To identify novel susceptibility loci and replicate previously known loci, we performed imputation-based association analysis with 6,382,276 SNPs while accounting for individual admixture. We validated the association analysis using adaptive permutation tests (n = 109). We identified a novel genome-wide significant locus near IRS1/miR-5702 (Pcorrected = 1.98 × 10−8) and eight novel suggestive loci (Pcorrected 0.8) with lead SNPs from four suggestive loci (ARMC9, DIAPH3, IFLDT1, and ENTPD3) were associated with differential gene expression (3.5 × 10−95 < p < 1.0 × 10−2) across diverse tissues. These loci are involved in cellular proliferation and invasion—pathways prominent in lupus and nephritis. Our study highlights the utility of GWAS in an admixed Egyptian population for delineating new genetic associations and for understanding SLE pathogenesis

EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial

More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University Münster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369